Annette North - Aug 30, 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
EVP, General Counsel & Secty.
Signature
/s/ Annette North
Stock symbol
TPTX
Transactions as of
Aug 30, 2021
Transactions value $
-$630,000
Form type
4
Date filed
8/31/2021, 05:26 PM
Previous filing
Jun 16, 2021
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Options Exercise $170K +10K +80.87% $17.00* 22.4K Aug 30, 2021 Direct F1
transaction TPTX Common Stock Sale -$800K -10K -44.71% $80.00 12.4K Aug 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Options Exercise $0 -10K -6.47% $0.00 145K Aug 30, 2021 Common Stock 10K $17.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
F2 One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.